Search

everythinglearnresearchcommunity

for

Search:↓

The study found that higher levels of ET-1 and SCF in early-stage dermal papilla cells improve their ability to regenerate hair follicles.

Nexin 1 helps control hair growth in young rats.

Women with hair loss had lower IGF-1 levels.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

Camellia sinensis seed flavonoids can reduce skin inflammation and damage from UV rays.

The system improved diabetic wound healing in rats.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

Rosemary may help with wound healing and hair growth by increasing VEGF.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The treatment effectively reduces hair loss and improves hair growth with minimal side effects.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Melamax® protects skin from UV damage and reduces inflammation and oxidative stress.

Gentamicin-loaded exosomes improve healing of infected diabetic wounds in mice.

Androgenetic alopecia negatively impacts mental health, suggesting a need for psychological support in treatment.

SQSTM1 is linked to increased risk of alopecia areata.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1RA therapy may increase the risk of hair loss.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Early genetic testing and zinc therapy are crucial for managing acrodermatitis enteropathica effectively.

GLP-1 agonists may help treat certain skin conditions.

Researchers created an efficient method to extract DNA from marmoset hair, avoiding blood chimerism.

Angiopoietin-1 helps hair cells survive and grow, making it a potential treatment for hair loss.